Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-24 @ 5:09 PM
NCT ID:
NCT02162550
Eligibility Criteria:
Inclusion Criteria:
* males and females of any race and ethnicity with T2DM, HbA1c of ≥6.5% and ≤10.0% on diet only
* take stable doses of oral antihyperglycemic agents with or without long-acting insulin
* must have a regular primary care provider (PCP) that is amenable to patient study participation and will facilitate (blinded to the treatment) the research team's study protocol efforts
Exclusion Criteria:
* type 1 diabetes mellitus (T1DM)
* current or recent glucagon-like peptide 1 receptor (GLP-1R) agonist use
* contraindications to MRI (e.g., claustrophobia, ferromagnetic materials, body habitus inappropriate for MRI exam)
* screening carotid ultrasound plaque thickness of \<0.75 mm, prior or anticipated carotid stenting or endarterectomy
* recent CVD (past 6 months) or other major illness or conditions affecting risk (e.g., pancreatitis, severe renal disease) or personal or family history of medullary thyroid carcinoma
* patients with Multiple Endocrine Neoplasia syndrome type 2
* serious hypersensitivity to exenatide or any product components
* severe gastrointestinal disease, or pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
75 Years
Study:
NCT02162550
Study Brief:
Protocol Section:
NCT02162550